Benjamin F. Edwards & Company’s LeMaitre Vascular LMAT Stock Holding History

Benjamin F. Edwards & Company’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-57	Closed	-$3K	–	1859
2022 Q4	$3K	Hold	57	–	–	﹤0.01%	1678
2022 Q3	$3K	Hold	57	–	–	﹤0.01%	1660
2022 Q2	$3K	Hold	57	–	–	﹤0.01%	1639
2022 Q1	$3K	Hold	57	–	–	﹤0.01%	1616
2021 Q4	$3K	Hold	57	–	–	﹤0.01%	1599
2021 Q3	$3K	Hold	57	–	–	﹤0.01%	1598
2021 Q2	$3K	Hold	57	–	–	﹤0.01%	1587
2021 Q1	$3K	Hold	57	–	–	﹤0.01%	1575
2020 Q4	$2K	Hold	57	–	–	﹤0.01%	1535
2020 Q3	$2K	Hold	57	–	–	﹤0.01%	1577
2020 Q2	$2K	Hold	57	–	–	﹤0.01%	1583
2020 Q1	$1K	Hold	57	–	–	﹤0.01%	1660
2019 Q4	$2K	Hold	57	–	–	﹤0.01%	1775
2019 Q3	$2K	Buy	+57	New	+$1.82K	﹤0.01%	1752

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Benjamin F. Edwards & Company's LMAT Position: Q1 2023 in Review

Benjamin F. Edwards & Company sold out of LeMaitre Vascular (LMAT) in Q1 2023, closing a stake of 57 shares — an estimated $3K sold.

Benjamin F. Edwards & Company first reported a position in LMAT in Q3 2019 and held it in 14 quarters. The position peaked at $3K in Q4 2022. 184 funds tracked by Wall St. Rank hold LMAT as of Q1 2023.

Benjamin F. Edwards & Company reported no remaining LeMaitre Vascular position as of Q1 2023 after selling out during the quarter.
Benjamin F. Edwards & Company sold 57 LeMaitre Vascular shares in Q1 2023, an estimated $3K.
Benjamin F. Edwards & Company first reported a position in LeMaitre Vascular in Q3 2019 and held it in 14 quarters.
Benjamin F. Edwards & Company's LeMaitre Vascular position peaked at $3K in Q4 2022.
184 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2023.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2023, filed 27 Apr 2023.